These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15037158)
1. Isoprostanes and the liver. Moore K Chem Phys Lipids; 2004 Mar; 128(1-2):125-33. PubMed ID: 15037158 [TBL] [Abstract][Full Text] [Related]
2. F2-isoprostanes are not just markers of oxidative stress. Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380 [TBL] [Abstract][Full Text] [Related]
3. Isoprostanes and hepatic fibrosis. Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C Mol Aspects Med; 2008; 29(1-2):43-9. PubMed ID: 18061254 [TBL] [Abstract][Full Text] [Related]
4. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157 [TBL] [Abstract][Full Text] [Related]
5. F(2)-isoprostanes: sensitive biomarkers of oxidative stress in vitro and in vivo: a gas chromatography-mass spectrometric approach. Wiswedel I Methods Mol Biol; 2009; 580():3-16. PubMed ID: 19784591 [TBL] [Abstract][Full Text] [Related]
6. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Milne GL; Musiek ES; Morrow JD Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907 [TBL] [Abstract][Full Text] [Related]
7. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231 [TBL] [Abstract][Full Text] [Related]
9. [Isoprostanes--new possibility of the oxidative stress estimation]. Dołegowska B; Chlubek D Przegl Lek; 2004; 61(12):1410-4. PubMed ID: 15850339 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of melatonin on diquat-induced lipid peroxidation in vivo as assessed by the measurement of F2-isoprostanes. Zhang L; Wei W; Xu J; Min F; Wang L; Wang X; Cao S; Tan DX; Qi W; Reiter RJ J Pineal Res; 2006 May; 40(4):326-31. PubMed ID: 16635020 [TBL] [Abstract][Full Text] [Related]
11. Novel eicosanoids. Isoprostanes and related compounds. Roberts LJ; Brame CJ; Chen Y; Morrow JD Methods Mol Biol; 1999; 120():257-85. PubMed ID: 10343322 [TBL] [Abstract][Full Text] [Related]
12. Isoprostanes: an emerging role in vascular physiology and disease? Cracowski JL Chem Phys Lipids; 2004 Mar; 128(1-2):75-83. PubMed ID: 15037154 [TBL] [Abstract][Full Text] [Related]
13. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease]. Cracowski JL; Berdeaux O; Durand T Pathol Biol (Paris); 2005 Jul; 53(6):364-8. PubMed ID: 16004949 [TBL] [Abstract][Full Text] [Related]
14. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients. Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Kadiiska MB; Gladen BC; Baird DD; Graham LB; Parker CE; Ames BN; Basu S; Fitzgerald GA; Lawson JA; Marnett LJ; Morrow JD; Murray DM; Plastaras J; Roberts LJ; Rokach J; Shigenaga MK; Sun J; Walter PB; Tomer KB; Barrett JC; Mason RP Free Radic Biol Med; 2005 Mar; 38(6):711-8. PubMed ID: 15721981 [TBL] [Abstract][Full Text] [Related]
16. Insights into oxidative stress: the isoprostanes. Montuschi P; Barnes P; Roberts LJ Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157 [TBL] [Abstract][Full Text] [Related]